Senores Pharmaceuticals Ltd Financial Statement
*All values are in Rs. Cr
| Particulars | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|
| Revenue | 28.21 | 21.11 | 16.78 |
| Operating Expense | 20.98 | 14.60 | 12.01 |
| Net Profit | 2.70 | 2.01 | 1.07 |
| Net Profit Margin | 9.57 | 9.52 | 6.38 |
| Earning Per Share | 0.59 | 0.39 | 0.32 |
| EBIDTA | 6.73 | 6.11 | 4.80 |
| Effective Tax Rate | 5.39 | 7.37 | 5.87 |
| Particulars | Jun 2025 |
|---|---|
| Revenue | 28.21 |
| Operating Expense | 20.98 |
| Net Profit | 2.70 |
| Net Profit Margin | 9.57 |
| Earning Per Share | 0.59 |
| EBIDTA | 6.73 |
| Effective Tax Rate | 5.39 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Total Revenue Annual | 38.54 | 34.01 | 12.38 |
| Operating Expenses Annual | 45.82 | 34.07 | 14.16 |
| Operating Profit Annual | 14.71 | 6.78 | 5.01 |
| Interest Annual | 6.52 | 2.71 | 2.14 |
| Depreciation | 3.05 | 1.47 | 0.37 |
| Net Profit Annual | 3.69 | 0.81 | 1.20 |
| Tax Annual | 1.42 | 1.22 | 0.74 |
| Particulars | Mar 2025 |
|---|---|
| Total Revenue Annual | 38.54 |
| Operating Expenses Annual | 45.82 |
| Operating Profit Annual | 14.71 |
| Interest Annual | 6.52 |
| Depreciation | 3.05 |
| Net Profit Annual | 3.69 |
| Tax Annual | 1.42 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Cash Flow at the Beginning | 10.44 | 0.09 | 1.66 |
| Cash Flow from Operations | -20.40 | -19.26 | -43.41 |
| Cash Flow from Investing | -162.94 | -57.07 | -5.23 |
| Cash Flow from Financing | 532.62 | 86.68 | 47.08 |
| Cash Flow at the End | 359.72 | 10.44 | 0.09 |
| Particulars | Mar 2025 |
|---|---|
| Cash Flow at the Beginning | 10.44 |
| Cash Flow from Operations | -20.40 |
| Cash Flow from Investing | -162.94 |
| Cash Flow from Financing | 532.62 |
| Cash Flow at the End | 359.72 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| PBDIT Margin (%) | 38.17 | 19.94 | 40.47 |
| PBIT Margin (%) | 30.18 | 13.94 | 32.96 |
| PBT Margin (%) | 25.56 | 8.79 | 17.53 |
| Net PROFIT Margin (%) | 9.57 | 2.38 | 9.69 |
| Return On Networth / Equity (%) | 0.84 | 0.78 | 3.30 |
| Return On Networth /Employed (%) | 2.15 | 2.56 | 5.44 |
| Return On Assets (%) | 0.67 | 0.43 | 1.65 |
| Total Debt / Equity (X) | 0.23 | 0.78 | 1.04 |
| Asset Turnover Ratio (%) | 0.07 | 0.18 | 0.17 |
| Particulars | Mar 2025 |
|---|---|
| PBDIT Margin (%) | 38.17 |
| PBIT Margin (%) | 30.18 |
| PBT Margin (%) | 25.56 |
| Net PROFIT Margin (%) | 9.57 |
| Return On Networth / Equity (%) | 0.84 |
| Return On Networth /Employed (%) | 2.15 |
| Return On Assets (%) | 0.67 |
| Total Debt / Equity (X) | 0.23 |
| Asset Turnover Ratio (%) | 0.07 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Fixed Assets Annual | 27.68 | 11.05 | 4.76 |
| Total Current Assets Annual | 39.96 | 27.68 | 13.98 |
| Non Current Assets Annual | 245.90 | 84.04 | 41.19 |
| Total Shareholders Funds Annual | 168.12 | 38.92 | 33.69 |
| Total Assets Annual | 285.86 | 111.72 | 55.17 |
| Particulars | Mar 2024 |
|---|---|
| Fixed Assets Annual | 27.68 |
| Total Current Assets Annual | 39.96 |
| Non Current Assets Annual | 245.90 |
| Total Shareholders Funds Annual | 168.12 |
| Total Assets Annual | 285.86 |
EPS (INR)
Expected
4.28
Reported
4.60
Surprise
7.48%
Mar 2025
EPS beaten by 7.48%
Dec 2024
EPS beaten by -1.55%
Sep 2024
EPS beaten by 35.12%
